Boozman-hof Regional Eye Clinic Pa - Medicare in Rogers, AR

Boozman-hof Regional Eye Clinic Pa is a medicare enrolled "Ophthalmology" provider in Rogers, Arkansas. Their current practice location is 3737 W. Walnut, Rogers, Arkansas. You can reach out to their office (for appointments etc.) via phone at (479) 246-1700.

Boozman-hof Regional Eye Clinic Pa is licensed to practice in Arkansas (license number ) and it also participates in the medicare program. Boozman-hof Regional Eye Clinic Pa is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1548234669.

Contact Information

Boozman-hof Regional Eye Clinic Pa
3737 W. Walnut,
Rogers, AR 72757-1353
(479) 246-1700
(479) 631-2629



Healthcare Provider's Profile

Full NameBoozman-hof Regional Eye Clinic Pa
TypeFacility
SpecialityOphthalmology
Location3737 W. Walnut, Rogers, Arkansas
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1548234669
  • Provider Enumeration Date: 02/15/2006
  • Last Update Date: 07/23/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 4981628245
  • Enrollment ID: O20060125000692

Medical Identifiers

Medical identifiers for Boozman-hof Regional Eye Clinic Pa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1548234669NPI-NPPES
112304722MedicaidAR
101143002MedicaidAR

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (Arkansas)Secondary
207W00000XOphthalmology (Arkansas)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Boozman-hof Regional Eye Clinic Pa acts as a billing entity for following providers:
Provider NameChristopher S Woodward
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1992779938
PECOS PAC ID: 2567586514
Enrollment ID: I20100828000023

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameDaniel T Sines
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1508028218
PECOS PAC ID: 7810043858
Enrollment ID: I20110906000545

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameMichael Ray Waggoner
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1295963999
PECOS PAC ID: 2365685229
Enrollment ID: I20141022000498

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameMary C Sullivan
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1871935122
PECOS PAC ID: 7618199316
Enrollment ID: I20141113000982

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameAustin P Bell
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1093008302
PECOS PAC ID: 5294971743
Enrollment ID: I20160616000101

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameSamantha Devlin
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1750732616
PECOS PAC ID: 0648545475
Enrollment ID: I20180626001471

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie Stanley Moss
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1043747595
PECOS PAC ID: 0941566947
Enrollment ID: I20180627003190

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameAndrew James Hickman
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1407342371
PECOS PAC ID: 1658629936
Enrollment ID: I20180802001334

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameRyan Bunch
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1306225214
PECOS PAC ID: 2769762756
Enrollment ID: I20210315001474

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Provider NameMellinda Stewart
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1104490044
PECOS PAC ID: 9234511270
Enrollment ID: I20220808000830

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Boozman-hof Regional Eye Clinic Pa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Boozman-hof Regional Eye Clinic Pa
3737 W. Walnut, P.o. Box 1353,
Rogers, AR 72757-1353

Ph: (479) 246-1700
Boozman-hof Regional Eye Clinic Pa
3737 W. Walnut,
Rogers, AR 72757-1353

Ph: (479) 246-1700

News Archive

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

Flutie Foundation, Autism Speaks join HP's initiative to create touch-based platforms

Autism Speaks, the world's largest autism science and advocacy organization, and the Doug Flutie Jr. Foundation for Autism have joined HP's "Hacking Autism" initiative, which seeks new ideas for touch technology applications beneficial to people with autism.

House panel may stall action on health pricing disclosure bills

Proposals to make the price of health care services and products more transparent to consumers has attracted bipartisan support on a House panel, but the subcommittee's chairman, Rep. Frank Pallone, D-N.J., would not say whether he would allow such legislation to move forward. Having just passed the health overhaul legislation, Pallone said he thought Congress should devote energy to initiatives "outside of health care" (McCarthy, 5/7).

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

Read more News

› Verified 6 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.